Jim B. Robbins CPA serves as Principal Financial Officer and Administration, Principal Accounting and Financial Officer of the Company. Mr. Robbins joined the Company as Vice President of Finance in July 2014 and was promoted to Vice President of Finance and Administration in May 2017. In May 2018, Mr. Robbins assumed expanded responsibilities and was appointed as the Company’s Principal Accounting Officer, and in November 2018, Mr. Robbins became the Principal Accounting and Financial Officer. He has over 25 years of accounting and finance experience in both industry and public accounting. Prior to joining the Company, Mr. Robbins provided accounting, finance and business consulting services for various biotech companies. From 2010 to 2012 he served as Vice President of Finance and Administration for Auxogyn, Inc., a privately held medical technology company focused on advancing women’s reproductive health by translating scientific discoveries in early embryo development into clinical solutions that improve patient outcomes in vitro fertilization (IVF) procedures. He served as Director of Finance and Vice President of Finance from 2004 to 2010 for Micrus Endovascular, Inc., a company which develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Prior to Micrus Endovascular, Mr. Robbins served at Genitope Corporation as Corporate Controller, a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. From 1995 to 2001, he served in management positions for high technology companies including Extricity, Inc., InVision Technologies, Inc., and Truevision, Inc. Mr. Robbins was in the audit practice of Price Waterhouse, LLP from 1987 to 1995. He received his Bachelor of Business Administration with a concentration in accounting from the University of Texas at Austin and is a Certified Public Accountant.
As the Principal Financial Officer and Administration i Principal Accounting and Financial Officer of Viveve Medical Inc, the total compensation of Jim Robbins at Viveve Medical Inc is $597,859. There are 3 executives at Viveve Medical Inc getting paid more, with Scott Durbin having the highest compensation of $2,983,570.
Jim Robbins is 56, he's been the Principal Financial Officer and Administration i Principal Accounting and Financial Officer of Viveve Medical Inc since 2018. There are 6 older and 4 younger executives at Viveve Medical Inc. The oldest executive at Viveve Medical Inc is Arlene Morris, 68, who is the Independent Director.
Jim's mailing address filed with the SEC is 345 Inverness Dr S #250, Englewood, CO 80112, USA.
Over the last 8 years, insiders at Viveve Medical Inc have traded over $444,564 worth of Viveve Medical Inc stock and bought 3,021,700 units worth $13,021,042 . The most active insiders traders include Sachs Group Incgoldman Sach..., Daniel Janney oraz Capital Management, Llcston.... On average, Viveve Medical Inc executives and independent directors trade stock every 80 days with the average trade being worth of $83. The most recent stock trade was executed by Sachs Group Incgoldman Sach... on 30 September 2019, trading 92,425 units of VIVE stock currently worth $444,564.
viveve provides women low risk, high reward medical procedures that promote personal health and wellness. the company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide.
Viveve Medical Inc executives and other stock owners filed with the SEC include: